-
公开(公告)号:AU2007239498A1
公开(公告)日:2007-10-25
申请号:AU2007239498
申请日:2007-04-19
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: DINKLO THEODORUS , ROOSBROECK YVES EMIEL MARIA VAN , DUFFY JAMES EDWARD STEWART , LESAGE ANNE SIMONE JOSEPHINE , BRUYN MARCEL FRANS LEOPOLD DE , MACDONALD GREGOR JAMES , THURING JOHANNES WILHELMUS JOHN F , KEYBUS FRANS ALFONS MARIA VAN DEN , ZHUANG WEI
IPC: C07D401/04 , A61K31/4196 , A61P25/00 , C07D249/08 , C07D405/04
Abstract: The present invention relates to 3-aniline-5-aryl triazole derivatives and analogues or pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, according to Formula (I). The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulator having the capability to increase the efficacy of nicotinic receptor agonists.
-
公开(公告)号:AU2008223793B2
公开(公告)日:2012-08-23
申请号:AU2008223793
申请日:2008-03-07
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: OWENS ANDREW PATE , PILATTE ISABELLE NOELLE CONSTANCE , MARCONNET-DECRANE LAURENCE FRANCOISE BERNADETTE , ANGIBAUD PATRICK RENE , ROUX BRUNO , FREYNE EDDY JEAN EDGARD , ADELINET CHRISTOPHE DENIS , STORCK PIERRE-HENRI , MACRITCHIE JACQUELINE ANNE , MEVELLEC LAURENCE ANNE , BOURDREZ XAVIER MARC , PONCELET VIRGINIE SOPHIE , MEYER CHRISTOPHE , PASQUIER ELISABETH THERESE JEANNE , DUFFY JAMES EDWARD STEWART , VIALARD JORGE EDUARDO
IPC: C07D215/22 , A61K31/4704
Abstract: The present invention provides compounds of Formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds, wherein R, R, R, R, R, R, R, n, m and X have defined meanings.
-
公开(公告)号:SI2134691T1
公开(公告)日:2012-06-29
申请号:SI200830607
申请日:2008-03-07
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: VIALARD JORGE EDUARDO , ANGIBAUD PATRICK RENE , MEVELLEC LAURENCE ANNE , MEYER CHRISTOPHE , FREYNE EDDY JEAN EDGARD , PILATTE ISABELLE NOELLE CONSTANCE , ROUX BRUNO , PASQUIER ELISABETH THERESE JEANNE , BOURDREZ XAVIER MARC , ADELINET CHRISTOPHE DENIS , MARCONNET-DECRANE LAURENCE FRANCOISE BERNADETTE , MACRITCHIE JACQUELINE ANNE , DUFFY JAMES EDWARD STEWART , OWENS ANDREW PATE , STORCK PIERRE-HENRI , PONCELET VIRGINIE SOPHIE
IPC: C07D215/00 , A61K31/00
-
公开(公告)号:ES2381446T3
公开(公告)日:2012-05-28
申请号:ES08717511
申请日:2008-03-07
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: VIALARD JORGE EDUARDO , ANGIBAUD PATRICK RENE , MEVELLEC LAURENCE ANNE , MEYER CHRISTOPHE , FREYNE EDDY JEAN EDGARD , PILATTE ISABELLE NOELLE CONSTANCE , ROUX BRUNO , PASQUIER ELISABETH THERESE JEANNE , BOURDREZ XAVIER MARC , ADELINET CHRISTOPHE DENIS , MARCONNET-DECRANE LAURENCE FRANCOISE BERNADETTE , MACRITCHIE JACQUELINE ANNE , DUFFY JAMES EDWARD STEWART , OWENS ANDREW PATE , STORCK PIERRE-HENRI , PONCELET VIRGINIE SOPHIE
IPC: C07D215/22 , A61K31/4704
Abstract: Compuesto de fórmula (I), las formas de N-óxido, las sales de adición farmacéuticamente aceptables y las formas estereoquímicamente isoméricas del mismo, en los que m es 0, 1 ó 2 y cuando m es 0 entonces se pretende que sea un enlace directo; n es 0, 1, 2, 3 ó 4 y cuando n es 0 entonces se pretende que sea un enlace directo; X es un enlace directo, CR10R11, (C=O)NR8, NR8, O o C≡C; R1 es arilo o Het; en los que arilo es fenilo o naftalenilo; en los que Het es tienilo, pirrolilo, pirrolinilo, oxazolilo, tiazolilo, imidazolilo, pirazolilo, isoxazolilo, isotiazolilo, oxadiazolilo, triazolilo, tetrazolilo, tiadiazolilo, furanilo, piperidinilo, piridinilo, piridazinilo, pirimidinilo, piperazinilo, pirazinilo, triazinilo, indolizinilo, azaindolizinilo, indolilo, indolinilo, benzotienilo, indazolilo, benzoxazolilo, bencimidazolilo, benzofuranilo, benzotiazolilo, benzotriazolilo, cromanilo, purinilo, quinolinilo, cinolinilo, ftalazinilo, quinazolinilo, quinoxazolinilo, naftiridinilo o pteridinilo; dos átomos de carbono en el arilo o Het pueden formar un puente (es decir, formando un resto bi o tricíclico) con un radical bivalente seleccionado de -O-CH2-CH2-O- (a-1), -CH2-O-CH2-O- (a-2), -O-CH2-CH2-CH2- (a-3), -O-CH2-CH2-NR8- (a-4), -O-CR8 2-O- (a-5), -O-CH2-CH2- (a-6), -CH2-N-CH2-CH2- (a-7), -(CH2)3- (a-8), o -(CH2)4- (a-9); cada arilo, Het, arilo en puente o Het en puente puede estar sustituido con uno, dos, tres, cuatro o cinco sustituyentes seleccionados cada uno independientemente de hidrógeno, halo, ciano, nitro, hidroxicarbonilo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-6, aminocicloalquilo C3-6, haloalquilo C1-6, trihaloalquilo C1-6, alquilcarbonilo C1-6, alquiloxicarbonilo C1-6, alquenilcarbonilo C2-6, oxima, alquiloxima C1-6, amidoxima, -CC-CH2O55 CH3, -CC-CH2N(CH3)2, -CC-Si(CH3)3, hidroxialquilo C1-6, hidroxialquenilo C2-6, hidroxialquinilo C2-6, cianoalquilo C1- 6, cianoalquenilo C2-6, aminocarbonilalquilo C1-6, alquilsulfonil C1-6-alquilo C1-6, alquilsulfonil C1-6-alquenilo C2-6, alquilsulfonil C1-6-alquinilo C1-6, -PO(O-alquilo C1-6)2, -B(OH)2, -SCH3, SF5, alquilsulfonilo C1-6, -NR8R9, alquil C1-6- NR8R9, -OR8, -alquil C1-6-OR8, -CONR8R9, piperidinilalquilo C1-6, piperazinilalquilo C1-6, alquil C1-6-piperazinilalquilo C1-6, morfolinilalquilo C1-6, piperidinilo, piperazinilo, alquil C1-6-piperazinilo, morfolinilo, fenilo, tienilo, pirazolilo, pirrolilo, pirrolidinilo, piridinilo, pirimidinilo, oxadiazolilo, imidazolilo, imidazolilalquinilo C2-6, alquil C1-6- imidazolilalquinilo C2-6, cianopiridinilo, fenilalquilo C1-6, fenilalquenilo C2-6, morfolinilalquilo C1-6, alquiloxi C1-6-fenilo, trihaloalquil C1-6-fenilo, metilpirazolilo, halopirimidinilo o dimetilaminopirrolidinilo; R2 es hidrógeno, metilo, etilo, propilo, cicloalquilo C3-6, cicloalquil C3-6-metilo, fluoro, fenilo, cianofenilo o trifluorometilo; R3 es metilo, etilo, propilo, hidroximetilo, halo, trifluorometilo, metiloxilo o alquilcarbonilo C1-6; R4 es hidrógeno, halo, metilo, aminocarbonilo, hidroxiaminocarbonilo, NR8R9-alquilo C1-6-, cianometilo, hidroximetilo o Het; cada R5, R6 y R7 se selecciona independientemente de hidrógeno, halo, alquiloxilo C1-6, ciano, alquilo C1-6, -OCH2CH2NR8R9, -CH2OCH2CH2NR8R9, -OCH2CH2CH2NR8R9 15 o alquiloxi C1-6-alquiloxilo C1-6; cada R8 y R9 se selecciona independientemente de hidrógeno, halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, carbonilo, alquilsulfonil C1-6-alquilo C1-6, alquiloxi C1-6-alquilo C1-6, hidroxialquilo C1-6, dihidroxialquilo C1-6, cianoalquilo C1-6, trihaloalquilo C1-6, fenilalquilo C1-6, (dialquil C1-6)-aminoalquilo C1-6, alquilsulfonilo C1-6, morfolinilalquilo C1-6, morfolinilcarbonilo, piperazinilalquilo C1-6, alquil C1-6-piperazinilalquilo C1-6, piperidinilalquilo C1-6, tiomorfolinilalquilo C1-6, cicloalquil C3-6-metilo, piridinilo, pirimidinilo, fenilo, halofenilo, oxanilalquilo C1-6, alquilsulfonil C1-6-alquilo C1-6 o alquil C1-6-carbonilaminoalquilo C1-6; cada R10 y R11 se selecciona independientemente de hidrógeno, metilo, hidroxilo, o tomados junto con el átomo de carbono al que están unidos pueden formar un anillo de ciclopropilo o un radical de fórmula C(=O).
-
公开(公告)号:EA016289B1
公开(公告)日:2012-03-30
申请号:EA200870448
申请日:2007-04-19
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: THURING JOHANNES WILHELMUS JOHN F , MACDONALD GREGOR JAMES , LESAGE ANNE SIMONE JOSEPHINE , ZHUANG WEI , DE BRUYN MARCEL FRANS LEOPOLD , VAN DEN KEYBUS FRANS ALFONS MARIA , VAN ROOSBROECK YVES EMIEL MARIA , DINKLO THEODORUS , DUFFY JAMES EDWARD STEWART
IPC: C07D401/04 , A61K31/4196 , A61P25/00 , C07D249/08 , C07D405/04
Abstract: Настоящееизобретениеотноситсяк производным 3-анилин-5-арилтриазолаи иханалогамилиихфармацевтическиприемлемымсолям, способамихполучения, содержащимихфармацевтическимкомпозициями ихприменениюв терапиив соответствиис формулой (I). Данноеизобретение, вчастности, относитсяк положительнымаллостерическиммодуляторамникотиновыхрецепторовацетилхолина, такимкакположительныйаллостерическиймодулятор, обладающийспособностьюусиливатьэффективностьагонистовникотиновогорецептора.
-
公开(公告)号:BRPI0710819A2
公开(公告)日:2011-08-23
申请号:BRPI0710819
申请日:2007-04-19
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: THURING JOHANNES WILHELMUS JOHN F , MACDONALD GREGOR JAMES , LESAGE ANNE SIMONE JOSEPHINE , ZHUANG WEI , DE BRUYN MARCEL FRANS LEOPOLD , VAN DEN KEYBUS FRANS ALFONS MARIA , VAN ROOSBROECK YVES EMIEL MARIA , DINKLO THEODORUS , DUFFY JAMES EDWARD STEWART
IPC: C07D401/04 , A61K31/4196 , A61P25/00 , C07D249/08 , C07D405/04
Abstract: The present invention relates to 3-aniline-5-aryl triazole derivatives and analogues or pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, according to Formula (I). The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulator having the capability to increase the efficacy of nicotinic receptor agonists.
-
公开(公告)号:HK1135375A1
公开(公告)日:2010-06-04
申请号:HK09111816
申请日:2009-12-16
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: THURING JOHANNES WILHELMUS JOHN F , MACDONALD GREGOR JAMES , LESAGE ANNE SIMONE JOSEPHINE , ZHUANG WEI , DE BRUYN MARCEL FRANS LEOPOLD , DEN KEYBUS FRANS ALFONS MARIA VAN , ROOSBROECK YVES EMIEL MARIA VAN , DINKLO THEODORUS , DUFFY JAMES EDWARD STEWART
IPC: C07D20060101 , A61K20060101 , A61P20060101
Abstract: The present invention relates to 3-aniline-5-aryl triazole derivatives and analogues or pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, according to Formula (I). The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulator having the capability to increase the efficacy of nicotinic receptor agonists.
-
公开(公告)号:NO20084744A
公开(公告)日:2008-11-10
申请号:NO20084744
申请日:2008-11-10
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: BRUYN MARCEL FRANS LEOPOLD DE , LESAGE ANNE SIMONE JOSEPHINE , ROOSBROECK YVES EMIEL MARIA VAN , MACDONALD GREGOR JAMES , KEYBUS FRANS ALFONS MARIA VAN , THURING JOHANNES WILHELMUS JOH , ZHUANG WEI , DINKLO THEODORUS , DUFFY JAMES EDWARD STEWART
IPC: C07D401/04 , A61K31/4196 , A61P25/00 , C07D249/08 , C07D405/04
CPC classification number: C07D249/08 , C07D249/14 , C07D401/04 , C07D405/04 , C07D405/14 , C07D413/14 , C07D491/044 , C07D491/048
-
公开(公告)号:CA2678248C
公开(公告)日:2016-06-28
申请号:CA2678248
申请日:2008-03-07
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: VIALARD JORGE EDUARDO , ANGIBAUD PATRICK RENE , MEVELLEC LAURENCE ANNE , MEYER CHRISTOPHE , FREYNE EDDY JEAN EDGARD , PILATTE ISABELLE NOELLE CONSTANCE , ROUX BRUNO , PASQUIER ELISABETH THERESE JEANNE , BOURDREZ XAVIER MARC , ADELINET CHRISTOPHE DENIS , MARCONNET-DECRANE LAURENCE FRANCOISE BERNADETTE , MACRITCHIE JACQUELINE ANNE , DUFFY JAMES EDWARD STEWART , OWENS ANDREW PATE , STORCK PIERRE-HENRI , PONCELET VIRGINIE SOPHIE
IPC: C07D215/22 , A61K31/4704
Abstract: The present invention provides compounds of Formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds, wherein R1, R2, R3, R4, R5, R6, R7, n, m and X have defined meanings.
-
公开(公告)号:AU2007239498B2
公开(公告)日:2012-08-23
申请号:AU2007239498
申请日:2007-04-19
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: DINKLO THEODORUS , LESAGE ANNE SIMONE JOSEPHINE , DE BRUYN MARCEL FRANS LEOPOLD , VAN ROOSBROECK YVES EMIEL MARIA , MACDONALD GREGOR JAMES , ZHUANG WEI , DUFFY JAMES EDWARD STEWART , VAN DEN KEYBUS FRANS ALFONS MARIA , THURING JOHANNES WILHELMUS JOHN F
IPC: C07D401/04 , A61K31/4196 , A61P25/00 , C07D249/08 , C07D405/04
Abstract: The present invention relates to 3-aniIine-5-aryl triazole derivatives and analogues or pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, according to Formula (I). The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulator having the capability to increase the efficacy of nicotinic receptor agonists.
-
-
-
-
-
-
-
-
-